Cohort Study of Factors Contributing to Mortality Two Months after Exacerbation of COPD According to Patient Destination from Emergency Department
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2015, Vol 5, Issue 2
Abstract
Background: We aimed to determine the mortality two months after exacerbation of chronic obstructive pulmonary disease (eCOPD) and to identify factors associated with mortality, comparing patients admitted to wards and those discharged to home from the emergency department. Methods: This prospective multicentre study included all consecutive patients presenting with eCOPD at emergency departments in 16 public hospitals in Spain. Clinical variables were recorded from a standardized questionnaire. Independent predictors of mortality were modelled by logistic regression analysis. The calibration and discriminative power of the models for the two groups (discharged and admitted) were estimated by the Hosmer-Lemeshow test and the area under the curve (AUC), respectively. Bootstrap methods were applied for internal validation. Results: 2487 patients were included; 1537 (62%) of these were admitted to wards. A total of 155 (6.2%; 95% CI: 5.2% - 7.1%) patients had died at 2 months: mortality was four times higher in patients admitted than in patients discharged. Age ≥ 80 years, Charlson score >2, and pronounced dyspnoea were independent factors for mortality in both groups; in admitted patients, Glasgow scale, baseline treatments for COPD, previous heart disease, complications during hospitalization, and corticoids at discharge were also independent factors. Conclusions: In eCOPD, age, comorbidities, and dyspnoea are important for short-term prognosis in both patients admitted to wards and those discharged to home. In patients admitted to wards, the severity of baseline disease and eCOPD and corticoid treatment affect the short-term prognosis.
Authors and Affiliations
Marisa Baré, Concepción Montón, Xavier Pomares, Juli Font, Núria Torà, Cristina Estirado, José Maria Quintana, Ana Santiago, Silvia Vidal, The IRYSS-COPD Appropriateness Study Group .
Keywords
Related Articles
- EP ID EP348096
- DOI 10.9734/BJMMR/2015/11853
- Views 62
- Downloads 0
Skin Expression of Advanced Glycation End Products (AGEs), Their Receptor (RAGE) and Glyoxalase-I (GLO-I) in Patients with Diabetic Neuropathy
Advanced Glycation End Products (AGEs), their receptor (RAGE) and their detoxifying enzyme Glyoxalase-I (GLO-I) have been implicated in the development of experimental diabetic peripheral neuropathy (DPN). However, few s...
Mortality Rate Pre-assessment Based on Trips Score
Treatment and care for newborn babies are provided at medical centres by personnel with the required education and experience using special equipment. Similar to the situation in many other countries, centres with such c...
Parental Influence on Sickle Cell Crisis among Patients Attending Secondary Facilities in Abeokuta South Local Government Area, Ogun State
Introduction: Sickle Cell Disease (SCD), the most common genetic disorder amongst Black people and one of the major chronic non-communicable diseases (NCD) affecting children, poses a significant psychosocial burden, not...
Immune Responses and Vaccine Development for Cytomegalovirus Infections
Aims: (1) To review the published literature on immune biology of host-Cytomegavovirus (CMV) interactions and to discuss the host immune responses against viral infection, providing insights into the complex interplay be...
A Novel Transglutaminase-1 Missense Mutation in a Palestinian Family with Autosomal Recessive Congenital Ichthyosis: A Case Report
This work presents the molecular genetics investigation of a male neonate referred to our genetics laboratory with the diagnosis of classical lamellar ichthyosis (one form of autosomal recessive congenital ichthyosis). T...